{"id":"NCT01644500","sponsor":"Eli Lilly and Company","briefTitle":"A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes Mellitus","officialTitle":"The Efficacy and Safety of Once-Weekly, Subcutaneous Dulaglutide Monotherapy Compared to Glimepiride in Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-07","primaryCompletion":"2014-08","completion":"2014-08","firstPosted":"2012-07-19","resultsPosted":"2015-12-17","lastUpdate":"2019-09-18"},"enrollment":737,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Dulaglutide","otherNames":["LY2189265"]},{"type":"DRUG","name":"Glimepiride","otherNames":[]},{"type":"DRUG","name":"Placebo as Capsules","otherNames":[]},{"type":"DRUG","name":"Placebo as SC Injection","otherNames":[]}],"arms":[{"label":"1.5 mg Dulaglutide","type":"EXPERIMENTAL"},{"label":"0.75 mg Dulaglutide","type":"EXPERIMENTAL"},{"label":"Glimepiride","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to examine if once-weekly dulaglutide is efficient and safe compared to glimepiride in participants with type 2 diabetes mellitus who have inadequate glycemic control with oral antihyperglycemic medication (OAM) or are OAM-na√Øve.","primaryOutcome":{"measure":"Change From Baseline in HbA1c at 26 Weeks","timeFrame":"Baseline, 26 Weeks","effectByArm":[{"arm":"1.5 mg Dulaglutide","deltaMin":-1.48,"sd":0.069},{"arm":"0.75 mg Dulaglutide","deltaMin":-1.22,"sd":0.069},{"arm":"Glimepiride","deltaMin":-0.92,"sd":0.069}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG001 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":11},"locations":{"siteCount":30,"countries":["China","South Korea","Taiwan"]},"refs":{"pmids":["32857293","32621083","32277401","32219675","31183384"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":244},"commonTop":["Hyperlipidaemia","Diarrhoea","Nasopharyngitis","Nausea","Lipase increased"]}}